Thus, the rate of TP53 LOH in LFS tumors is substantially higher than previously reported21.This could be due to our focus on pediatric cancers and/or our use of the more sensitive method of WGS as compared to Sanger sequencing approaches used by others. The gene discussed is TP53; the disease is cancer.